“However, it is known that metformin stimulates catabolic pathways through the activation of adenosine monophosphate –activated protein kinase (AMPK) [2] and that a synthetic activator of AMPK, 5-aminoimidazole4-carboxamide ribofuranoside (AICAR) inhibits adipogenesis in the pre-adipocyte cell line, 3T3-L1 [3].”